Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Thrombocytopenia
•
COVID-19
•
Hematology
•
Benign Hematology
•
ITP
•
COVID-19 virus
Would you recommend the bivalent COVID-19 booster in a patient with suspected ITP from COVID-19 vaccine?
Related Questions
Patient with known ITP, now having a relapse in the setting of a mitral valve vegetation and responding to steroids and IVIG, would you consider a TPO agonist and wean steroids?
How would you treat a young woman with refractory ITP surrounding pregnancy who responds to fostamatinib?
Is there a correlation between spleen size and degree of thrombocytopenia?
Do you prefer avatrombopag over eltrombopag in ITP?
What are your options for refractory ITP after steroids and TPO for elderly patients?
In a patient with a history of HIT, how would you reintroduce Heparin?
How do you treat a patient with warfarin failure, with therapeutic INR 2-3 at the time of DVT, and no underlying malignancy or hypercoagulable state?
How would you manage warfarin in a patient with APLS and alcoholic cirrhosis?
How is transferrin saturation a reliable indicator for any parameter if serum iron is not reliable?
For a patient with ESRD on hemodialysis with recurrent AV fistula thrombosis and a finding of Protein C deficiency based on decreased plasma activity level on thrombophilia workup, what is recommended in terms of anticoagulation management?
